Private Wealth Management Group’s Pacira BioSciences PCRX Stock Holding History

Private Wealth Management Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85K	Hold	82	–	–	﹤0.01%	1104
2025 Q4	$2.12K	Hold	82	–	–	﹤0.01%	1063
2025 Q3	$2.11K	Hold	82	–	–	﹤0.01%	1099
2025 Q2	$1.96K	Hold	82	–	–	﹤0.01%	1087
2025 Q1	$2.04K	Hold	82	–	–	﹤0.01%	1046
2024 Q4	$1.54K	Buy	82 +59	+257%	+$1.04K	﹤0.01%	1186
2024 Q3	$347	Sell	23 -117	-84%	-$2K	﹤0.01%	1452
2024 Q2	$4.01K	Buy	140 +123	+724%	+$3.5K	﹤0.01%	791
2024 Q1	$497	Buy	+17	New	+$522	﹤0.01%	1447

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return